MedPath

The Accuracy of Continuous Glucose Monitoring Systems in Critically Ill Patients

Completed
Conditions
Hyperglycemia in Critically Ill Patients
Registration Number
NCT07201155
Lead Sponsor
Nanfang Hospital, Southern Medical University
Brief Summary

Abstract: Hyperglycemia, hypoglycemia, and glucose variability in ICU patients are associated with adverse outcomes. Continuous Glucose Monitoring Systems (CGMS) offer dynamic glucose monitoring and early warnings to improve glucose management. This study aims to evaluate the accuracy and reliability of the CGMS (Microtech AiDEX®) in critically ill patients and its performance under acidosis conditions, providing evidence for its application in the ICU.

Methods: This prospective observational study included patients with BG\>180 mg/dL on intravenous insulin therapy. Blood glucose was monitored using point-of-care (POC), arterial blood gas analysis (aBG), and CGMS. CGMS values were paired 1:1 with POC and aBG values. CGMS accuracy was evaluated using MARD, ISO 15197-2013, CLSI POCT12-A3, and Clarke Error Grid Analysis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
55
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
MARDFrom enrollment to discharge/completion of 14-day CGMS wear.

MARD was calculated as the average of absolute percentage differences between paired glucose measurements: MARD = (1/n) × Σ(\|CGMS-Reference\|/Reference) × 100%.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Nanfang Hospital, Southern Medical University

🇨🇳

Guangzhou, Guangdong, China

Nanfang Hospital, Southern Medical University
🇨🇳Guangzhou, Guangdong, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.